Schedule 13G ownership disclosure
PROKIDNEY CORP
Ordinary Shares · CUSIP: G7S53R104
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 10,058,924 · Class: 7.8%
- Morgan Stanley Investment Management Inc.
Shares: 10,043,784 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000348
- Form type
- SCHEDULE 13G/A
- Filer
- MORGAN STANLEY
- CIK
- CIK 895421
- Filed
- May 06, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership